Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
British Journal of Cancer|December 17, 2019
Dual-specificity protein phosphatase DUSP4 regulates response to MEK inhibition in BRAF wild-type melanomaAvinash Gupta, Christopher Towers, Frances Willenbrock, et al.
Trials|August 1, 2021
An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept studyArjune Sen, Mary Akinola, Xin You Tai, et al.
The Lancet. Oncology|August 8, 2017
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trialsHarpreet S Wasan, Peter Gibbs, Navesh K Sharma, et al.
Epilepsia Open|October 14, 2024
Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: a pilot, double-blind placebo-controlled crossover trialArjune Sen, Sofia Toniolo, Xin You Tai, et al.
BMJ (Clinical Research Ed.)|May 16, 2022
Visualising harms in publications of randomised controlled trials: consensus and recommendationsRachel Phillips, Suzie Cro, Graham Wheeler, et al.
Gut|March 21, 2014
A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMSDan Rosmarin, Claire Palles, Alistair Pagnamenta, et al.
Eclinicalmedicine|June 16, 2022
Effect of moderate to high intensity aerobic exercise on blood pressure in young adults: The TEPHRA open, two-arm, parallel superiority randomized clinical trialWilby Williamson, Adam James Lewandowski, Odaro John Huckstep, et al.
BMC Cancer|June 7, 2022
Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)David J Barnes, Peter Dutton, Øyvind Bruland, et al.
Alzheimer'S Research & Therapy|February 18, 2021
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects?Grazia Daniela Femminella, Nicholas R Livingston, Sanara Raza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2014
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysisDan Rosmarin, Claire Palles, David Church, et al.
Pageof 4